Quipt Home Medical (QIPT) Fundamental Analysis: Revenue, Earnings & Valuation

8.97 / 10

Outperform

Fundamental assessment rates Outperform with an 8.97/10 score. Asset‑MV, net profit growth, EPS and cash‑flow metrics are strong, while PB‑ROE and operating revenue lag, yielding a mixed but overall robust profile.

Analysis Checks(6/10)

Revenue-MV

Value0.86

Score0/3

Weight-42.62%

1M Return-6.43%

Net cash flow from operating activities per share (YoY growth rate %)

Value5.67

Score2/3

Weight17.43%

1M Return1.67%

PB-ROE

Value-0.52

Score0/3

Weight-17.20%

1M Return-1.98%

Basic earnings per share (YoY growth rate %)

Value-50.00

Score2/3

Weight15.86%

1M Return1.57%

Total profit (YoY growth rate %)

Value-55.38

Score2/3

Weight27.36%

1M Return2.58%

Net cash flow from operating activities (YoY growth rate %)

Value6.53

Score1/3

Weight9.14%

1M Return0.92%

Diluted earnings per share (YoY growth rate %)

Value-50.00

Score2/3

Weight10.41%

1M Return1.03%

Operating revenue (YoY growth rate %)

Value-0.23

Score0/3

Weight-16.28%

1M Return-1.72%

Asset-MV

Value-0.55

Score2/3

Weight59.73%

1M Return5.07%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value-58.23

Score2/3

Weight36.16%

1M Return3.36%

Is QIPT fundamentally strong?

QIPT scores 8.97/10 on fundamentals and holds a Discounted valuation at present. Backed by its -0.94% ROE, -3.85% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and -53.33% earnings growth, these metrics solidify its Outperform investment rating.

QIPT(Delisted)

Analysis Checks(6/10)